Showing 2 of 2 recruiting trials for “Well-differentiated liposarcoma”
A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma
👨⚕️ Olayode Babatunde, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Feb 2025View details ↗
Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas
👨⚕️ Nelly FIRMIN, MD, Institut Régional du Cancer de Montpellier (ICM)📍 1 site📅 Started Aug 2020View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →